PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. However, the impact of the new law will reverberate in the industry for years to come.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Copyright Clearance Center

DECEMBER 10, 2024

The survey was conducted at the Alliances annual US conference held this year in Philadelphia, which gathered more than 200 industry experts to collaborate on topics such as AI regulation, harmonization of data standards, and patient-centricity. To find out more about membership or to suggest project ideas, visit www.pistoiaalliance.org.

Prescription 52

Prescription Patients FDA Safety 52

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Prescription refills can now be placed with a simple click on a patient portal. Reconsider the Role of Packaging.

Retail 97

Retail Marketing Healthcare Healthcare 97

Pharmaceutical Technology

JUNE 1, 2023

For context, in January 2023, the FDA accepted Intercept’s resubmission of its NDA for OCA as a Class 2 resubmission (which has a six-month review period in NASH) and set a Prescription Drug User Fee Act (PDUFA) date of 22 June 2023.

FDA 52

FDA Side effects Prescription Patients 52

PM360

JUNE 16, 2023

The Role of the COVID-19 Pandemic on the Diagnostics Market Landscape Diagnostic testing has always been seen as a valuable tool for healthcare providers (HCPs) to accurately diagnose illness and ensure that patients receive necessary medical care. 2 Patients are the ones reaping the benefits of peace of mind—and early diagnosis.

Marketing 52

Marketing Healthcare Healthcare Medical 52

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. What’s more, tying specific ad campaigns to patient outcomes with traditional TV advertising can be challenging. Best-in-class healthcare marketers are already planning for next year.

Marketing 52

Marketing Media Healthcare Healthcare 52

Evolve Your Success

NOVEMBER 28, 2023

Using innovative AI-assisted devices redefines treatment approaches and envisions a future where technology greatly enhances patient care. Join us as Charles explores the game-changing HiDO device , a groundbreaking technology designed to transform patient care and medication management. Let’s break that down a little bit.

Medical 52

Medical Medical sales Sales Patients 52

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. Patient behavior on insulin: Part D plans will have limited opportunity to adjust strategy for 2023, given bids are locked in. The IRA affects several components of the U.S.

Government 97

Government Manufacturing Prescription Marketing 97

Pharma Leaders

JUNE 9, 2023

Cosette Pharmaceuticals has acquired the worldwide rights to prescription drug, Intraros, from Endorecherche’s subsidiary Endoceutics. It is expected to be launched in Asian market in 2025. Intrarosa is said to be the only prescription drug that provides estrogen as well as androgen to treat moderate-to-severe dyspareunia.

Prescription 52

Prescription Distribution Pharma Pharmaceutical 52

Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Such a change would sharply increase the number of people covered under this program.

Healthcare 52

Healthcare Healthcare Government Insurance 52